Blog
RSS FeedPosted by Michael Wonder on 15 Jul 2017
Disappointment as government delays pharma-friendly policies
14 July 2017 - The government’s Accelerated Access Review was supposed to herald a new age of innovation in the ...
Posted by Michael Wonder on 13 Jul 2017
NICE backs Humira, Enbrel and Stelara for plaque psoriasis in children
13 July 2017 - AbbVie’s Humira, Pfizer’s Enbrel, and Janssen’s Stelara are being recommended as options for treating plaque psoriasis ...
Posted by Michael Wonder on 13 Jul 2017
New improved BNF and BNFC app launched
13 July 2017 - Following the recent launch by the publishers of the British National Formulary (BNF) and British National Formulary ...
Posted by Michael Wonder on 10 Jul 2017
Drug industry to challenge NICE over new cost limits
10 July 2017 - The drug industry is going to court to challenge the authority of the National Institute for ...
Posted by Michael Wonder on 10 Jul 2017
ABPI applies for Judicial Review over new procedures that restrict access to cost-effective medicines
10 July 2017 - Following a story published today in the Financial Times, the Association of the British Pharmaceutical Industry ...
Posted by Michael Wonder on 10 Jul 2017
A new treatment option for people with kidney cancer
10 July 2017 - People with advanced kidney cancer are set to benefit from a new treatment, after NICE has ...
Posted by Michael Wonder on 09 Jul 2017
Pressure on NHS finances drives new wave of postcode rationing
4 July 2017 - Rationing of treatment in the NHS in England is on the rise again, with patients around ...
Posted by Michael Wonder on 06 Jul 2017
One in three RA patients rejecting meds because of cost
6 July 2017 - One in three people with rheumatoid arthritis in England are not taking their medicine as prescribed ...
Posted by Michael Wonder on 05 Jul 2017
Pfizer facing NICE showdown over leukaemia drug
3 July 2017 - Pfizer’s Besponsa leukaemia drug has been approved in Europe, but the company is heading for a ...
Posted by Michael Wonder on 05 Jul 2017
Strensiq new deal paves way for NICE approval of life saving drug
5 July 2017 - An agreement has been reached that means more people with a rare life threatening disease can be ...
Posted by Michael Wonder on 05 Jul 2017
Merck’s Keytruda, Lilly’s Lartruvo available via CDF
5 July 2017 - Patients with certain forms of lung cancer or sarcoma have now gained access to two new ...
Posted by Michael Wonder on 05 Jul 2017
NICE terminates another three cancer medicine assessments
5 July 2017 - This brings the number of terminated assessments for 2017 to nine. ...
Posted by Michael Wonder on 04 Jul 2017
£4 drug which triples a woman's chances of getting pregnant is being blocked by the NHS
5 July 2017 - NHS guidelines reject the drug and instead say that couples should 'keep trying'. ...
Posted by Michael Wonder on 03 Jul 2017
Xiapex gets recommendation to be made available on National Health Service in England
30 June 2017 - Swedish Orphan Biovitrum today announces that for the first time people in England with the disabling ...
Posted by Michael Wonder on 29 Jun 2017
NICE issues draft guidance on the use of Olumiant
29 June 2017 - After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination on baricitinib ...